Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
29m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
29m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
29m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
29m agoFirst Quantum Minerals Reports First Quarter 2026 Results
29m agoDistrict Metals Announces $10 Million Private Placement Financing
Reviva Pharmaceuticals Holdings Inc. logo

Reviva Pharmaceuticals Holdings Inc.

About

Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
Apr 15 2026
Reviva Announces Letter to Shareholders
Mar 30 2026
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
Mar 23 2026
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
Jan 8 2026
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia

Financials

Revenue
$0
Market Cap
$9.22 M
EPS
-5.48

Community Chat

Ask AI

6ix6ixAIEvents